A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

The commercials make it sound so simple: "If it's COVID, Paxlovid." But the slogan, catchy though it may be, belies a harsher reality that some public health and elected officials have long ...

Opinions expressed by Forbes Contributors are their own. Author of best seller AARP Roadmap for the Rest of Your Life. Just over three years after the world heard about Covid, and despite getting ...

In clinical trials, 5.6 percent of patients who received Paxlovid experienced dysgeusia. While very unpleasant, this side effect is temporary and not cause for concern.

What to avoid with this at-home COVID-19 treatment Paxlovid is a combination antiviral medication that contains nirmatrelvir ...

A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes and emphasizing the need for clinical trials.

Hello. I'm Dr. John Whyte. I'm the Chief Medical Officer at WebMD. You test positive for COVID, and you're not feeling well. What do you do? Specifically, what's the role of antivirals? You might ...

These findings counter clinical trial results published in June which found that Paxlovid was safe to take but did not lessen ...

A new study from UC San Francisco researchers indicates that an extended course of Paxlovid, an antiviral medication, may ...

Participants took Paxlovid courses ranging from 7.5 to 30 days, often in combination with other medications or supplements, complicating the assessment of the drug's isolated effects.

The findings run counter to a clinical trial which found no benefit from Paxlovid in long COVID patients WEDNESDAY, Jan. 8, 2024 (HealthDay News) -- The antiviral pill Paxlovid might help some ...